Molecular remission of Philadelphia/bcr-abl-positive acute myeloid leukaemia after treatment with anti-CD33 calicheamicin conjugate (gemtuzumab ozogamicin, CMA-6776)
Loading...
Date
Authors
Vetten, M.P. de
Jansen, J.H. Joop
Reijden, B.A. Bert
Berger, M.S.
Zijlmans, J.M.J.M.
Lowenberg, B.